{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:44:21Z","timestamp":1792248261158,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ajog.2017.05.045","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T08:46:21Z","timestamp":1496133981000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":265,"title":["Premenstrual disorders"],"prefix":"10.1016","volume":"218","author":[{"given":"Kimberly Ann","family":"Yonkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4514-4804","authenticated-orcid":false,"given":"Michael K.","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.05.045_bib1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneurpsyc.1931.02230110151009","article-title":"The hormonal causes of premenstrual tension","volume":"26","author":"Frank","year":"1931","journal-title":"Arch Neurol Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/bmj.1.4818.1007","article-title":"The premenstrual syndrome","volume":"1","author":"Greene","year":"1953","journal-title":"Br Med J"},{"key":"10.1016\/j.ajog.2017.05.045_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","article-title":"Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus","volume":"14","author":"O'Brien","year":"2011","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2017.05.045_bib4","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington (DC): American Psychiatric Association, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.ajog.2017.05.045_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1176\/ajp.141.2.163","article-title":"Premenstrual syndromes: overview from a methodologic perspective","volume":"141","author":"Rubinow","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib6","first-page":"e73","article-title":"Royal College of Obstetricians and Gynecologists. Management of premenstrual symptoms","volume":"124","author":"Green","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.05.045_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archgenpsychiatry.2011.1368","article-title":"Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets","volume":"69","author":"Hartlage","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/jwh.2006.0230","article-title":"Differences in symptom scores and health outcomes in premenstrual syndrome","volume":"16","author":"Borenstein","year":"2007","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2017.05.045_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejogrb.2012.01.017","article-title":"Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China","volume":"162","author":"Qiao","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2017.05.045_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-0327(01)00458-X","article-title":"Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles","volume":"70","author":"Cohen","year":"2002","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ajog.2017.05.045_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S003329170800322X","article-title":"The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women","volume":"39","author":"Gehlert","year":"2009","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2017.05.045_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1258\/mi.2012.012013","article-title":"Epidemiology of premenstrual symptoms and disorders","volume":"18","author":"Dennerstein","year":"2012","journal-title":"Menopause Int"},{"key":"10.1016\/j.ajog.2017.05.045_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/01443610400023049","article-title":"Obesity as a risk factor for premenstrual syndrome","volume":"26","author":"Masho","year":"2005","journal-title":"J\u00a0Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1017\/S0033291710002321","article-title":"Health advantage for black women: patterns in pre-menstrual dysphoric disorder","volume":"41","author":"Pilver","year":"2011","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2017.05.045_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0033291701004925","article-title":"Prevalence, incidence and stability of premenstrual dysphoric disorder in the community","volume":"32","author":"Wittchen","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2017.05.045_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/aje\/kws363","article-title":"Intake of selected minerals and risk of premenstrual syndrome","volume":"177","author":"Chocano-Bedoya","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2017.05.045_bib17","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1089\/jwh.2010.2128","article-title":"Adiposity and the development of premenstrual syndrome","volume":"19","author":"Bertone-Johnson","year":"2010","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2017.05.045_bib18","doi-asserted-by":"crossref","first-page":"e28422","DOI":"10.5812\/ijem.28422","article-title":"Comparison of metabolic and hormonal profiles of women with and without premenstrual syndrome: a community-based cross-sectional study","volume":"14","author":"Hashemi","year":"2016","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.05.045_bib19","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4088\/JCP.v65n1004","article-title":"Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder","volume":"65","author":"Perkonigg","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/jwh.2013.4674","article-title":"Early life emotional, physical, and sexual abuse and the development of premenstrual syndrome: a longitudinal study","volume":"23","author":"Bertone-Johnson","year":"2014","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2017.05.045_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0447.1990.tb06479.x","article-title":"Premenstrual depression predicts future major depressive disorder","volume":"81","author":"Graze","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ajog.2017.05.045_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0033291700032761","article-title":"Genetic and environmental factors in the etiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study","volume":"22","author":"Kendler","year":"1992","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2017.05.045_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.162.4.481","article-title":"The premenstrual syndrome: a twin study","volume":"162","author":"Condon","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib24","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2017.16101113","article-title":"Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels","author":"Schmidt","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/0269881113490327","article-title":"SSRIs and the female brain\u2013potential for utilizing steroid-stimulating properties to treat menstrual cycle-linked dysphorias","volume":"27","author":"Lovick","year":"2013","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.ajog.2017.05.045_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2011.03.061","article-title":"Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons","volume":"191","author":"Backstrom","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.ajog.2017.05.045_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/npp.2015.246","article-title":"5alpha-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder","volume":"41","author":"Martinez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ajog.2017.05.045_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psyneuen.2017.02.031","article-title":"Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)\u2013a randomized controlled trial","volume":"80","author":"Bixo","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2017.05.045_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/JCP.0b013e3181ad8825","article-title":"Allopregnanolone levels before and after selective serotonin reuptake inhibitor treatment of premenstrual symptoms","volume":"29","author":"Gracia","year":"2009","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2017.05.045_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/0269881113512910","article-title":"SSRIs probably counteract premenstrual syndrome by inhibiting the serotonin transporter","volume":"28","author":"Eriksson","year":"2014","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.ajog.2017.05.045_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0278-5846(88)90061-9","article-title":"A\u00a0regional study of sex differences in rat brain serotonin","volume":"12","author":"Carlsson","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.biopsych.2005.10.019","article-title":"Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field","volume":"60","author":"Hiroi","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/frne.2001.0225","article-title":"Diverse actions of ovarian steroids in the serotonin neural system","volume":"23","author":"Bethea","year":"2002","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.ajog.2017.05.045_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-0327(94)90059-0","article-title":"Acute tryptophan depletion aggravates premenstrual syndrome","volume":"32","author":"Menkes","year":"1994","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ajog.2017.05.045_bib35","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1176\/appi.ajp.159.11.1876","article-title":"Effects of metergoline on symptoms in women with premenstrual dysphoric disorder","volume":"159","author":"Roca","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"Premenstrual syndrome","volume":"371","author":"Yonkers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.05.045_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11920-015-0628-3","article-title":"Premenstrual dysphoric disorder: epidemiology and treatment","volume":"17","author":"Hantsoo","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.ajog.2017.05.045_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11920-015-0619-4","article-title":"Neuroimaging the menstrual cycle and premenstrual dysphoric disorder","volume":"17","author":"Comasco","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.ajog.2017.05.045_bib39","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1002\/hbm.22486","article-title":"Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder","volume":"35","author":"Comasco","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.ajog.2017.05.045_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2007.09.015","article-title":"Toward a functional neuroanatomy of premenstrual dysphoric disorder","volume":"108","author":"Protopopescu","year":"2008","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ajog.2017.05.045_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1176\/appi.ajp.2012.12030385","article-title":"Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study","volume":"170","author":"Baller","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0015-0282(16)59045-1","article-title":"Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial","volume":"47","author":"Prior","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.05.045_bib43","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0029-7844(95)00246-N","article-title":"The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome","volume":"86","author":"Sayegh","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/01674820209074672","article-title":"A\u00a0randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder","volume":"23","author":"Hunter","year":"2002","journal-title":"J\u00a0Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4088\/JCP.v58n0905","article-title":"Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome","volume":"58","author":"Halbreich","year":"1997","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib46","first-page":"Cd001396","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","volume":"6","author":"Marjoribanks","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.05.045_bib47","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.4088\/JCP.v67n1020","article-title":"Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies","volume":"67","author":"Kornstein","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib48","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jamapsychiatry.2015.1472","article-title":"Symptom-onset dosing of sertraline for the treatment of premenstrual dysphoric disorder: a randomized clinical trial","volume":"72","author":"Yonkers","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajog.2017.05.045_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.05.045_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib51","first-page":"27","article-title":"Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder","volume":"7","author":"Freeman","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2017.05.045_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2011.05.008","article-title":"Continuous oral levonorgestrel\/ethinyl estradiol for treating premenstrual dysphoric disorder","volume":"85","author":"Halbreich","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.05.045_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2011.09.010","article-title":"An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome","volume":"85","author":"Freeman","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.05.045_bib54","first-page":"Cd010503","article-title":"Non-contraceptive estrogen-containing preparations for controlling symptoms of premenstrual syndrome","volume":"3","author":"Naheed","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.05.045_bib55","first-page":"Cd003415","article-title":"Progesterone for premenstrual syndrome","volume":"3","author":"Ford","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.05.045_bib56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without \u2018add-back\u2019 therapy in treating premenstrual syndrome: a meta analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.05.045_bib57","first-page":"779","article-title":"Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial","volume":"84","author":"Brown","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib58","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM198411223112104","article-title":"The premenstrual syndrome: effects of \u201cmedical ovariectomy\u201d","volume":"311","author":"Muse","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.05.045_bib59","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.318.7195.1375","article-title":"Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review","volume":"318","author":"Wyatt","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2017.05.045_bib60","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajog.2017.02.028","article-title":"The treatment of premenstrual syndrome with preparations of Vitex agnus-castus: a systematic review and meta-analysis","volume":"217","author":"Verkaik","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib61","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/acm.2008.0493","article-title":"A\u00a0randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome","volume":"15","author":"Ozgoli","year":"2009","journal-title":"J\u00a0Altern Complement Med"},{"key":"10.1016\/j.ajog.2017.05.045_bib62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/11530120-000000000-00000","article-title":"The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Canning","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajog.2017.05.045_bib63","first-page":"2227","article-title":"Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS","volume":"80","author":"Thys-Jacob","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.05.045_bib64","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group","volume":"179","author":"Thys-Jacobs","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5468\/ogs.2017.60.1.100","article-title":"Effect of calcium on premenstrual syndrome: a double-blind randomized clinical trial","volume":"60","author":"Shobeiri","year":"2017","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.ajog.2017.05.045_bib66","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JCP.0b013e31829c7697","article-title":"A\u00a0pilot study to compare fluoxetine, calcium, and placebo in the treatment of premenstrual syndrome","volume":"33","author":"Yonkers","year":"2013","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2017.05.045_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily Record of Severity of Problems (DRSP): reliability and validity","volume":"9","author":"Endicott","year":"2006","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2017.05.045_bib68","first-page":"302","article-title":"Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the Calendar of Premenstrual Experiences","volume":"76","author":"Mortola","year":"1990","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2017.05.045_bib69","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"2","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.05.045_bib70","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jwh.2016.5941","article-title":"The influence of cyclic hormonal contraception on expression of premenstrual syndrome","volume":"26","author":"Yonkers","year":"2017","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2017.05.045_bib71","first-page":"1219","article-title":"Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder","volume":"100","author":"Halbreich","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib72","doi-asserted-by":"crossref","first-page":"139.e1","DOI":"10.1016\/j.ajog.2009.03.016","article-title":"Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder","volume":"201","author":"Segebladh","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.045_bib73","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0015-0282(00)01707-6","article-title":"Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome","volume":"75","author":"Di Carlo","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.05.045_bib74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00016348809004191","article-title":"Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo","volume":"67","author":"Hammarback","year":"1988","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817306749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817306749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:18:17Z","timestamp":1757589497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817306749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0002937817306749"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.05.045","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Premenstrual disorders","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}